APA citiranje

Bajor, D. L., Mick, R., Riese, M. J., Huang, A. C., Sullivan, B., Richman, L. P., . . . Vonderheide, R. H. (2018). Long-term outcomes of a phase I study of agonist CD40 antibody and CTLA-4 blockade in patients with metastatic melanoma. Oncoimmunology.

Citação norma Chicago

Bajor, David L., et al. "Long-term Outcomes of a Phase I Study of Agonist CD40 Antibody and CTLA-4 Blockade in Patients With Metastatic Melanoma." Oncoimmunology 2018.

MLA citiranje

Bajor, David L., et al. "Long-term Outcomes of a Phase I Study of Agonist CD40 Antibody and CTLA-4 Blockade in Patients With Metastatic Melanoma." Oncoimmunology 2018.